
Advog 0.2
ERIS LIFE SCIENCES PVT LTD - 10 S
Standard delivery
Distributor inventory | Tablet
Sitagliptin 50 mg + Metformin Hydrochloride 850 mg (as immediate-release tablet)
Type 2 diabetes mellitus: to improve glycaemic control in adults when diet and exercise alone or metformin/sitagliptin monotherapy is inadequate.
Sitagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), leading to glucose-dependent increased insulin release and reduced glucagon. Metformin decreases hepatic glucose production and improves insulin sensitivity, reducing glucose absorption and improving peripheral uptake.
Take exactly as prescribed. Usually taken orally with meals to reduce stomach upset; swallow tablet whole with water. Do not crush/chew unless advised. Dose is individualized based on kidney function and blood sugar; follow your doctor’s schedule.
Common side effects of Zomelis Met 50/850MG Tab may include:

ERIS LIFE SCIENCES PVT LTD - 10 S
Standard delivery
ERIS LIFE SCIENCES PVT LTD - 10 S
Standard delivery
ERIS LIFE SCIENCES PVT LTD - 10 S
Standard delivery
ERIS LIFE SCIENCES PVT LTD - 10 S
Standard delivery
ERIS LIFE SCIENCES PVT LTD - 15 S
Standard delivery

ERIS LIFE SCIENCES PVT LTD - tablet - 15 S
Standard delivery

ERIS LIFE SCIENCES PVT LTD - 10 S
Standard delivery

ERIS LIFE SCIENCES PVT LTD - 15 S
Standard delivery
Prescription only. Risk of lactic acidosis with metformin (medical emergency): higher risk in kidney impairment, dehydration, severe infection, hypoxia, heart failure, liver disease, or excess alcohol; stop and seek help if fast breathing, severe weakness, muscle pain, abdominal pain, or drowsiness occur. Assess renal function before and during therapy; dose adjustment/avoid in significant renal impairment. Temporarily stop metformin before iodinated contrast procedures and major surgery as advised. Sitagliptin: rare pancreatitis and severe joint pain; stop and consult if severe persistent abdominal pain. Monitor for hypoglycaemia if used with insulin/sulfonylureas.